# West Pharmaceutical (WST) — Analyst Forecast

WST · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/wst/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | $420.00 |
| Oct 7, 2026 | Barclays | Maintained | Overweight | $440.00 |
| Sep 22, 2026 | Morgan Stanley | Upgraded | Equal-Weight → Overweight | $400.00 |
| Sep 9, 2026 | UBS | Maintained | Buy | $415.00 |
| Aug 3, 2026 | Citigroup | Maintained | Buy | $412.00 |
| Jul 27, 2026 | Evercore ISI Group | Maintained | Outperform | $425.00 |
| Jul 13, 2026 | BNP Paribas | Initiated Coverage | Outperform | $447.00 |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | $365.00 |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | $410.00 |
| Jul 2, 2026 | Keybanc | Maintained | Overweight | $390.00 |
| Jun 9, 2026 | Barclays | Upgraded | Equal-Weight → Overweight | $400.00 |
| Jun 2, 2026 | Wolfe Research | Initiated Coverage | Outperform | — |
| Jun 2, 2026 | Stephens & Co. | Maintained | Overweight | $360.00 |
| May 29, 2026 | Morgan Stanley | Maintained | Equal-Weight | $325.00 |
| Apr 27, 2026 | Barclays | Maintained | Equal-Weight | $310.00 |
| Apr 14, 2026 | Barclays | Maintained | Equal-Weight | $275.00 |
| Feb 13, 2026 | Barclays | Maintained | Equal-Weight | $265.00 |
| Feb 3, 2026 | Evercore ISI Group | Maintained | Outperform | $320.00 |
| Dec 2, 2025 | Morgan Stanley | Initiated Coverage | Equal-Weight | $285.00 |
| Oct 29, 2025 | TD Cowen | Initiated Coverage | Buy | $350.00 |

## Frequently Asked Questions

### What is the latest analyst rating on WST?

On Oct 13, 2026, TD Cowen maintained West Pharmaceutical at Buy with a price target of $420.00.

## Similar Stocks

- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock
- [CHE](https://www.lighthorse.io/tickers/che) — Chemed Corp

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).